ArticleScandinavian journal of medicine & science in sports2020
How many runners with new-onset Achilles tendinopathy develop persisting symptoms? A large prospective cohort study.
Article in Scandinavian journal of medicine & science in sports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 25 citations in OpenAlex.
- Recreational runners with Achilles tendinopathy have symmetrical single leg hopping mechanics, and contact duration is associated with vertical stiffness.BMC sports science, medicine & rehabilitation · 2026Article
- Neurophysiological characteristics accompanying runners with Achilles tendinopathy and their influence in triceps surae performance (PhD Academy Award).British journal of sports medicine · 2025Article
- Effect of foot position during plantarflexion on the neural drive to the gastrocnemii in runners with Achilles tendinopathy.European journal of applied physiology · 2025Article
- Epidemiology of insertional and midportion Achilles tendinopathy in runners: A prospective cohort study.Journal of sport and health science · 2024Article
- Lower motor unit discharge rates in gastrocnemius lateralis, but not in gastrocnemius medialis or soleus, in runners with Achilles tendinopathy: a pilot study.European journal of applied physiology · 2023Article
- Bibliometric Study of Exercise and Tendinopathy Research from 2001 to 2020.Medical science monitor : international medical journal of experimental and clinical research · 2022Article
- Intra- and Inter-Rater Reliability of Processing Ultrasound Tissue Characterization Scans in Midportion Achilles Tendinopathy.Translational sports medicine · 2022Article
- How many runners with new-onset Achilles tendinopathy develop persisting symptoms? A large prospective cohort study.Scandinavian journal of medicine & science in sports · 2020Article
- Stiffness of the Gastrocnemius-Achilles Tendon Complex Between Amateur Basketball Players and the Non-athletic General Population.Frontiers in physiology · 2020Article
- Are static foot posture and ankle dorsiflexion range of motion associated with Achilles tendinopathy? A cross-sectional study.Brazilian journal of physical therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
backgroundAchilles tendinopathy (AT) occurs in half of the elite runners. AT is a difficult-to-treat tendon disease, which may progress from new onset to a chronic state. It is unknown how many runners with new-onset AT develop persisting symptoms and which prognostic factors are associated with this course.
objectiveTo describe how many runners develop persisting symptoms 1 year after onset of reactive AT. STUDY
designProspective cohort study.
methodsRunners registering for a Dutch running event (5-42.2 km) were eligible for inclusion. Runners reporting new-onset AT between registration for the running event and 1 month after received a 1-year follow-up questionnaire. The 1-year follow-up questionnaire inquired about persisting symptoms (yes/no), running activity, and metabolic disorders. We calculated the percentage of runners with persisting symptoms and performed a multivariable logistic regression analysis to study the association between potential prognostic factors and persisting symptoms.
resultsOf 1929 participants, 100 runners (5%) reported new-onset AT. A total of 62 runners (62%) filled in the 1-year follow-up questionnaire. Persisting symptoms were reported by 20 runners (32%). A higher running distance per week before new-onset AT was associated with a lower risk of developing persisting symptoms (odds ratio (OR): 0.9, 95% confidence interval (CI): [0.9;1.0]). There was a positive trend toward an association between metabolic disorders and persisting symptoms (OR: 5.7, 95% CI: [0.9;36.2]).
conclusionOne third of runners develop persisting symptoms 1 year after new-onset AT. Interestingly, a higher running distance per week before new-onset AT potentially lowers the risk of developing persisting symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.